Federal Register #DEA-1747

DEA Notice: Experic LLC Application to Import Controlled Substances for Research and Clinical Trials

This DEA notice concerns Experic LLC's application to import controlled substances for research and clinical trials. - Government Buyer: - Department of Justice, Drug Enforcement Administration (DEA) - Applicant/Vendor: - Experic LLC - Products/Controlled Substances Requested: - Tetrahydrocannabinols (Drug Code 7370, Schedule I) - 5-Methoxy-N-Ndimethyltryptamine (Drug Code 7431, Schedule I) - Nabilone (Drug Code 7379, Schedule II) - Purpose and Requirements: - Importation strictly for internal research and clinical trial purposes - No authorization for importing finished dosage forms for commercial sale (FDA-approved or non-approved) - DEA is soliciting public comments and hearing requests regarding the application - OEMs: - No specific OEMs or manufacturers are named; only Experic LLC is listed as the applicant - Notable Details: - The substances are Schedule I and II controlled substances, requiring strict regulatory oversight - The registration, if granted, is limited in scope to research and clinical trials

Description

Experic LLC has applied to be registered as an importer of basic classes of controlled substances. The application is part of the DEA's process for registering importers of controlled substances and includes substances such as Tetrahydrocannabinols, 5-Methoxy-N-Ndimethyltryptamine, and Nabilone. Comments and objections can be submitted electronically until September 25, 2026, and written requests for a hearing must also be filed by this date. The registration will authorize import for internal research and clinical trial purposes only, excluding finished dosage forms for commercial sale.

View original listing